Sun Pharma offers to buy 100% stake in Taro in an all-cash deal
Sun pharmaceutical said on saturday it proposed to fully acquire israelbased taro pharmaceutical industries through a reverse triangular merger in the allcash deal sun pharma will acquire the shares at a price of 38 per ordinary share which will be payable in full at the closing of the proposed transaction sun pharma currently owns a 7848 stake in taro